These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7946771)

  • 1. Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators.
    Cowley AJ; Skene AM
    Br Heart J; 1994 Sep; 72(3):226-30. PubMed ID: 7946771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Double-blind clinical and echocardiographic study of oral enoximone versus placebo in severe cardiac insufficiency].
    Delorme G; Dubourg O; Jondeau G; Beauchet A; Arnal JF; Hardy A; Brun D; Dinanian S; Bock F; Bourdarias JP
    Arch Mal Coeur Vaiss; 1992 Jul; 85(7):1023-9. PubMed ID: 1449335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment.
    Dubourg O; Delorme G; Hardy A; Beauchet A; Tarral A; Bourdarias JP
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S33-42; discussion S43. PubMed ID: 2145237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.
    Uretsky BF; Jessup M; Konstam MA; Dec GW; Leier CV; Benotti J; Murali S; Herrmann HC; Sandberg JA
    Circulation; 1990 Sep; 82(3):774-80. PubMed ID: 2144216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the enoximone clinical trials program.
    Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
    J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral enoximone as a substitute for intravenous catecholamine support in end-stage congestive heart failure.
    Jondeau G; Dubourg O; Delorme G; Arnal JF; Chikli F; Kamoun L; Dumas C; Bourdarias JP
    Eur Heart J; 1994 Feb; 15(2):242-6. PubMed ID: 8005127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group.
    Narahara KA
    Am Heart J; 1991 May; 121(5):1471-9. PubMed ID: 1826806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group.
    Lowes BD; Higginbotham M; Petrovich L; DeWood MA; Greenberg MA; Rahko PS; Dec GW; LeJemtel TH; Roden RL; Schleman MM; Robertson AD; Gorczynski RJ; Bristow MR
    J Am Coll Cardiol; 2000 Aug; 36(2):501-8. PubMed ID: 10933364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
    Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
    Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enoximone on quality of life.
    Baligadoo SJ; Subratty H; Manraz M; Tarral A; Maiti D; Murday M
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S29-32. PubMed ID: 2145235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of enoximone therapy in patients with refractory heart failure.
    Dec GW; Fifer MA; Herrmann HC; Cocca-Spofford D; Semigran MJ
    Am Heart J; 1993 Feb; 125(2 Pt 1):423-9. PubMed ID: 8427136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy.
    Leier CV; Binkley PF; Starling RC; Huss-Randolph P
    Am Heart J; 1989 May; 117(5):1092-8. PubMed ID: 2523634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of enoximone in patients with heart failure uncontrolled by captopril and diuretics.
    Cowley AJ; Stainer K; Fullwood L; Muller AF; Hampton JR
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S45-52; discussion 52-3. PubMed ID: 2145238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure.
    Bader FM; Gilbert EM; Mehta NA; Bristow MR
    Congest Heart Fail; 2010; 16(6):265-70. PubMed ID: 21091611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative hemodynamic effects of intravenous digoxin and enoximone in severe chronic heart failure.
    Casella G; Cantelli I; Pavesi PC; Barbato G; Bracchetti D
    Cardiology; 1994; 85(5):303-10. PubMed ID: 7850820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomised, cross-over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):45-50. PubMed ID: 2450255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW
    Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.
    Cohn JN; Goldstein SO; Greenberg BH; Lorell BH; Bourge RC; Jaski BE; Gottlieb SO; McGrew F; DeMets DL; White BG
    N Engl J Med; 1998 Dec; 339(25):1810-6. PubMed ID: 9854116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of digoxin on the quality of life in patients with heart failure.
    Lader E; Egan D; Hunsberger S; Garg R; Czajkowski S; McSherry F
    J Card Fail; 2003 Feb; 9(1):4-12. PubMed ID: 12612867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of oral enoximone in pharmacologic bridging to cardiac transplantation.
    Bristow MR
    Z Kardiol; 1994; 83 Suppl 2():15-9. PubMed ID: 7522381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.